Question 1

What is ALS Pharma?

Accepted Answer

ALS Pharma is a Entity.

Question 2

How often does ALS Pharma appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was ALS Pharma first tracked by Ergen?

Accepted Answer

First tracked on Jun 24, 2026.

Question 4

When was ALS Pharma last mentioned in news?

Accepted Answer

Last active on Jun 24, 2026.

Question 5

What is ALS Pharma's current news sentiment?

Accepted Answer

Aggregate sentiment score: 75 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is ALS Pharma in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving ALS Pharma?

Accepted Answer

AL-S Pharma AP-101 Phase 2 Success (Jun 24, 2026, 6 articles).

Question 8

How did the "AL-S Pharma AP-101 Phase 2 Success" event impact ALS Pharma?

Accepted Answer

ALS Pharma announced positive Phase 2 clinical trial results for its lead program, IBM System/4 Pi, in treating ALS, demonstrating clinically meaningful disease modification and prolonged survival. This significantly advances their drug development and positions them for a Phase 3 trial.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.